2-(3-Chloropyrazin-2-yl)acetonitrile

Catalog No. :
ACPTEM791
CAS No. :
914360-88-6
Molecular Formula :
C6H4ClN3
Molecular Weight :
153.57

IUPAC Name:2-(3-chloropyrazin-2-yl)acetonitrile

2-(3-Chloropyrazin-2-yl)acetonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$82.00Login to see priceIn stockInquiry
250mg95%$109.00Login to see priceIn stockInquiry
1g95%$273.00Login to see priceIn stockInquiry
5g95%$999.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Chloropyrazin-2-yl)acetonitrile
IUPAC Name2-(3-chloropyrazin-2-yl)acetonitrile
MDL No.MFCD15146238
Molecular FormulaC6H4ClN3
Molecular Weight153.57
SMILESClC1=C(CC#N)N=CC=N1
InChI KeyQYOUXNLAVKGTBD-UHFFFAOYSA-N
Synonym914360-88-6 | 2-(3-Chloropyrazin-2-yl)acetonitrile | 3-Chloro-2-pyrazineacetonitrile | MFCD15146238 | DTXSID60551760 | (3-Chloropyrazin-2-yl)acetonitrile | AMY16167 | 2-(3-Chloro-2-pyrazinyl)acetonitrile | AKOS016005609 | PB11137 | AS-34544 | SY097046 | CS-0052282 | FT-0770365 | EN3
CAS No.914360-88-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACPTEM791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACPTEM791 route product structure diagram
    ACPTEM791914360-88-6 In Stock
Inquiry

2. ACPTEM791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACPTEM791 route product structure diagram
    ACPTEM791914360-88-6 In Stock
Inquiry

Comments (0)